hydroxychloroquine

Sanford Health News

The top doctor at Sanford Health says South Dakota will continue a pilot study of the drug hydroxychloroquine, but the drug will not go to people who are sick with COVID-19. 

Instead, researchers will look at the drug’s ability to prevent or lessen the severity of the disease. 

News: 10 - 17

Apr 17, 2020
SDPB

In this week's news podcast, leading state democrats and republicans reflect of the 2020 legislative session, Sanford Research joins us for a talk about hydroxychloroquine and the statewide clinical trial, and much more.

fda.gov

South Dakota is launching the first statewide trial of a possible treatment for COVID-19 in the nation. The trial drug typically treats malaria, lupus, and rheumatoid arthritis.   

President Donald Trump has pointed to hydroxychloroquine as a potential therapeutic for COVID-19, though its effectiveness has not yet been confirmed.

Governor Noem says she’s been asking the president and other members of his administration to allow South Dakota to launch a statewide trial. This weekend, the state received a shipment of the drug.